Cardiovascular Eligibility Criteria and Adverse Event Reporting in Combined Immune Checkpoint and VEGF Inhibitor Trials

Authors: Stephen Rankin, Benjamin Elyan, Robert Jones, Balaji Venugopal, Patrick B. Mark, Jennifer S. Lees, Mark C. Petrie, Ninian N. Lang

Published: 2024-02-27

DOI: 10.1016/j.jaccao.2023.12.010

Source: Full article

---

Abstract

No abstract found.